European Commission grants orphan drug designation to Altemia for sickle cell disease April 4, 2018 No Comments
Jiangsu Hengrui Medicine Co., Shanghai Hengrui Pharmaceutical Co. patent factor XIa inhibitors March 27, 2018 No Comments
Positive topline data from phase III study of ALXN-1210 in patients with PNH March 16, 2018 No Comments
RSS